The role of nuclear factor Kappa B in the pathogenesis of pulmonary diseases: Implications for therapy

American Journal of Respiratory Medicine

Volumn 2, Issue 3, 2003, Pages 211-219

  Wright, Jeffrey G ^a   Christman, John W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BORTEZOMIB; BUDESONIDE; CELL ADHESION MOLECULE; CHEMOKINE; CORTICOSTEROID; CURCUMIN; CYTOKINE; DROTRECOGIN; ENZYME; FLAVONOID; FORMOTEROL; GLUCOCORTICOID; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPRENOID; OLIGONUCLEOTIDE; PARTHENOLIDE; PHENOL DERIVATIVE; PROTEASOME INHIBITOR; SILIBININ;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ASTHMA; BIOLOGICAL MODEL; CARCINOGENESIS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG TARGETING; GENE EXPRESSION; GENE INDUCTION; HUMAN; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG DEPOSIT; LUNG DISEASE; LUNG INJURY; MINERAL DUST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RESPIRATORY DISTRESS; REVIEW; RISK FACTOR; SEPSIS; SOLID TUMOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0038266174     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256650     Document Type: Review

References (73)

1. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705-16
2. Schwartz MD, Moore EE, Moore FA, et al. Nuclear factor-kappaB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996; 24: 1285-92
3. Blackwell TS, Holden EP, Blackwell TR, et al. Activation of NF-kappaB in rat lung by treatment with endotoxin: modulation with N-acetyalcysteine. J Immunol 1996; 157: 1630-7
4. Ghosh S, May MJ, Kopp EB. NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-60
5. Henkel T, Machleidt T, Alkalay I, et al. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappaB. Nature 1993; 365: 182-5
6. Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to Interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 1999; 19: 4798-805
7. Zhong H, SuYang H, Erdjument-Bromage H, et al. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997; 89: 413-24
8. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, et al. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 1995; 15: 2689-96
9. Chen L-F, Fischle W, Verdin E, et al. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001; 293: 1653-7
10. Mercurio F, Manning AM. Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 1999; 11: 226-32
11. Opal SM, Huber CE. Bench-to-bedside review: toll-like receptors and their role in septic shock. Crit Care 2002; 6 (2): 125-36
12. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336 (15): 1066-71
13. Moine P, McIntyre R, Schwartz MD, et al. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 2000; 13 (2): 85-91
14. Shenkar R, Yum HK, Arcaroli J, et al. Interactions between CBP, NF-kappaB, and CREB in the lungs after hemorrhage and endotoxemia. Am J Physiol Lung Cell Mol Physiol 2001; 281 (2): L418-26
15. Pepperl S, Dorger M, Ringel F, et al. Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: role of AP-1 and NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2001; 280 (5): L905-13
16. Pugin J, Dunn I, Jolliet P, et al. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol 1998; 275 (6 Pt 1): L1040-50
17. Leeper-Woodford SK, Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-kappaB expression. Am J Physiol 1999; 276 (6 Pt 1): L909-16
18. Janssen-Heininger YM, Macara I, Mossman BT. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 1999; 20 (5): 942-52
19. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344 (10): 699-709
20. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29 (7 Suppl.): S48-51
21. Joyce DE, Grinnell BW. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 2002; 30 (5 Suppl.): S288-93
22. Zhao S, Qi Y, Liu X, et al. Activation of NF-kappa B in bronchial epithelial cells from children with asthma. Chin Med J (Engl) 2001; 114 (9): 909-11
23. Wilson SJ, Wallin A, Della-Cioppa G, et al. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001; 164 (6): 1047-52
24. Shukla A, Timblin C, BeruBe K, et al. Inhaled particulate matter causes expression of nuclear factor (NF)-kappaB-related genes and oxidant-dependent NF-kappaB activation in vitro. Am J Respir Cell Mol Biol 2000; 23 (2): 182-7
25. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510-3
26. Kim I, Moon S, Kim S, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001; 276 (10): 7614-20
27. Dikov M, Oyama T, Cheng P, et al. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells. Cancer Res 2001; 61 (5): 2015-21
28. Kasahara Y, Tuder R, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106 (11): 1311-9
29. Baldwin Jr AS. The NF-kappaB and IkappaB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-81
30. Nishikawa M, Kakemizu N, Ito T, et al. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 1999; 20: 189-98
31. Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor kappaB in pulmonary diseases. Chest 2000; 117: 1482-7
32. Teramoto S, Kume H. The role of nuclear factor-kappaB activation in airway inflammation following adenovirus infection and COPD. Chest 2000; 119 (4): 1294-5
33. Cafferata EGA, Guerrico AMG, Pivetta OH, et al. NF-kappaB activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1beta. J Biol Chem 2001; 276 (18): 15441-4
34. Brouillard F, Bouthier M, Leclerc T, et al. NF-kappa B mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1beta. J Biol Chem 2001; 276 (12): 9486-91
35. Venkatakrishnan A, Stecenko AA, King G, et al. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 2000; 23 (3): 396-403
36. Weber AJ, Soong G, Bryan R, et al. Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. Am J Physiol Lung Cell Mol Physiol 2001; 281 (1): L71-8
37. Scheid P, Kempster L, Griesenbach U, et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 2001; 17 (1): 27-35
38. DiMango E, Ratner AJ, Bryan R, et al. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998; 101 (11): 2598-605
39. Ghio AJ, Marshall BC, Diaz JL, et al. Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum. Am J Respir Crit Care Med 1996; 154 (3 Pt 1): 783-8
40. Drent M, van den Berg R, Haenen GR, et al. NF-kappaB activation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18 (1): 50-6
41. Kreipe H, Radzun HJ, Heidorn K, et al. Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis. Lab Invest 1990; 62 (6): 697-703
42. Conron M, Bondeson J, Pantelidis P, et al. Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-kappa b-dependent signaling pathways. Am J Respir Cell Mol Biol 2001; 25 (2): 141-9
43. Baldwin Jr AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107 (3): 241-6
44. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3 (3): 221-7
45. Rosell R, Taron M, O'Brate A. Predictive molecular markers in non-small cell lung cancer. Curr Opin Oncol 2001; 13 (2): 101-9
46. Jones DR, Broad RM, Madrid LV, et al. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann Thorac Cardiovasc Surg 2000; 70 (3): 930-6
47. Cusack JJ, Liu R, Baldwin Jr AS. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and xenograft models is overcome by inhibition of nuclear factor-kappa activation. Cancer Res 2000; 60: 2323-30
48. Haley KJ, Patidar K, Zhang F, et al. Tumor necrosis factor induces neuroendocrine differentiation in small cell lung cancer cell lines. Am J Physiol 1998; 275 (2 Pt 1): L311-21
49. Batra RK, Guttridge DC, Brenner DA, et al. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. Am J Respir Cell Mol Biol 1999; 21 (2): 238-45
50. Milligan SA, Nopajaroonsri C. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro. Anticancer Res 2001; 21 (1A): 39-44
51. Ding M, Shi X, Castranova V, et al. Predisposing factors in occupational lung cancer: inorganic minerals and chromium. J Environ Pathol Toxicol Oncol 2000; 19 (1-2): 129-38
52. Sacks M, Gordon J, Bylander J. Silica-induced pulmonary inflammation in rats: activation of NF-kappaB and its suppression by dexamethasone. Biochem Biophys Res Commun 1998; 253: 181-4
53. Kennedy T, Ghio AJ, Reed W, et al. Copper dependent inflammation and nuclear factor kappa B activation by particulate air pollution. Am J Respir Cell Mol Biol 1998; 19: 366-78
54. Takizawa H, Ohtoshi T, Kawasaki S, et al. Diesel exhaust particles induce NF-kB activity in human bronchial epithelial cells in vitro: importance in cytokine transcription. J Immunol 1999; 162: 4705-11
55. Quay JL, Reed W, Samet J, et al. Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kappaB activation. Am J Respir Cell Mol Biol 1998; 19: 98-106
56. Kawasaki S, Takizawa H, Takami K, et al. Benzene-extracted components are important for the major activity of diesel exhaust particles: effect on interleukin-8 gene expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2001; 24 (4): 419-26
57. Bonvallot V, Baeza-Squiban A, Baulig A, et al. Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epithelial cells and induce cytochrome p450 1A1 expression. Am J Respir Cell Mol Biol 2001; 25 (4): 515-21
58. Dai J, Churg A. Relationship of fiber surface iron and active oxygen species to expression of procollagen, PDGF-A, and TGF-beta(1) in tracheal explants exposed to amosite asbestos. Am J Respir Cell Mol Biol 2001; 24 (4): 427-35
59. Gilmour PS, Beswick PH, Brown DM, et al. Detection of surface free radical activity of respirable industrial fibres using supercoiled phi X174 RF1 plasmid DNA. Carcinogenesis 1995; 16: 2973-9
60. Janssen YM, Driscoll KE, Howard B, et al. Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am J Pathol 1997; 151 (2): 389-401
61. Janssen YM, Barchowsky A, Treadwell M, et al. Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci U S A 1995; 92 (18): 8458-62
62. Cheng N, Shi X, Ye J, et al. Role of transcription factor NF-kappaB in asbestos-induced TNFalpha response from macrophages. Exp Mol Pathol 1999; 66 (3): 201-10
63. Brown DM, Beswick PH, Donaldson K. Induction of nuclear translocation of NF-kappaB in epithelial cells by respirable mineral fibres. J Pathol 1999; 189 (2): 258-64
64. Robledo R, Mossman BT. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cell Physiol 1999; 180 (2): 158-66
65. Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmcol 2002; 54 (4): 453-72
66. Sheehan M, Wong HR, Hake PW, et al. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 2002; 61 (5): 953-63
67. Adams J, Palombella VJ, Sausville EA, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 1999; 59: 2615-22
68. Javelaud D, Poupon MF, Wietzerbin J, et al. Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. Int J Cancer 2002; 98 (2): 193-8
69. Romanelli A, Pedone C, Saviano M, et al. Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites. Eur J Biochem 2001; 268 (23): 6066-75
70. Ueno T, Sawa Y, Kitagawa-Sakakida S, et al. Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest. J Thorac Cardiovasc Surg 2001; 122 (4): 720-7
71. Sakaue G, Shimaoka M, Fukuoka T, et al. NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 2001; 12 (10): 2079-84
72. Tonita T, Takeuchi E, Tonita N, et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligo-nucleotides as a gene therapy. Arthritis Rheum 1999; 42 (12): 2532-42
73. Almawi WY, Melemedjian O. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J Mol Endocrinol 2002; 28 (2): 69-78